Table of Contents Europe ADHD Drugs Market Report 2012-2023 1 ADHD Drugs Overview 1.1 Product Overview and Scope of ADHD Drugs 1.2 Classification of ADHD Drugs by Product Category 1.2.1 Europe ADHD Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe ADHD Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Stimulants (Amphetamines, Methylphenidate) 1.2.4 Non-Stimulants 1.2.5 Antidepressants 1.2.6 Blood Pressure Medicines 1.3 Europe ADHD Drugs Market by Application/End Users 1.3.1 Europe ADHD Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Adults 1.3.3 Children 1.4 Europe ADHD Drugs Market by Region 1.4.1 Europe ADHD Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of ADHD Drugs (2012-2023) 1.5.1 Europe ADHD Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of ADHD Drugs 2.2 Raw Material Analysis of ADHD Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of ADHD Drugs 2.4 Other Costs Analysis of ADHD Drugs 2.5 Manufacturing Cost Structure Analysis of ADHD Drugs 2.6 Manufacturing Process Analysis of ADHD Drugs 2.7 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe ADHD Drugs Players/Suppliers Profiles and Sales Data 3.1 Eli Lilly 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 ADHD Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Eli Lilly Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Eli Lilly ADHD Drugs Volume in Different Applications and Its Application Share 3.2 Janssen Pharmaceuticals, Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 ADHD Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Janssen Pharmaceuticals, Inc. Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Different Applications and Its Application Share 3.3 Shire 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 ADHD Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Shire Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Shire ADHD Drugs Volume in Different Applications and Its Application Share 3.4 Perdue Pharma 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 ADHD Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Perdue Pharma Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Perdue Pharma ADHD Drugs Volume in Different Applications and Its Application Share 3.5 Glaxosmith Kline 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 ADHD Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Glaxosmith Kline Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Glaxosmith Kline ADHD Drugs Volume in Different Applications and Its Application Share 3.6 Novartis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 ADHD Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novartis Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novartis ADHD Drugs Volume in Different Applications and Its Application Share 3.7 Celltech Group 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 ADHD Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Celltech Group Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Celltech Group ADHD Drugs Volume in Different Applications and Its Application Share 3.8 Johnson & Johnson 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 ADHD Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Johnson & Johnson Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Johnson & Johnson ADHD Drugs Volume in Different Applications and Its Application Share 4 Europe ADHD Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe ADHD Drugs Market Competition by Players/Manufacturers 4.1.1 Europe ADHD Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe ADHD Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe ADHD Drugs Sales and Revenue by Type 4.2.1 Europe ADHD Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe ADHD Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe ADHD Drugs Sales and Revenue by Application 4.3.1 Europe ADHD Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe ADHD Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe ADHD Drugs Sales (K Units) by Application 5 Germany ADHD Drugs (Sales, Revenue and Price) 5.1 Germany ADHD Drugs Sales and Value (2012-2017) 5.1.1 Germany ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany ADHD Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany ADHD Drugs Sales (K Units) and Market Share by Type 5.3 Germany ADHD Drugs Sales (K Units) and Market Share by Application 6 UK ADHD Drugs (Sales, Revenue and Price) 6.1 UK ADHD Drugs Sales and Value (2012-2017) 6.1.1 UK ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK ADHD Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK ADHD Drugs Sales (K Units) and Market Share by Type 6.3 UK ADHD Drugs Sales (K Units) and Market Share by Application 7 France ADHD Drugs (Sales, Revenue and Price) 7.1 France ADHD Drugs Sales and Value (2012-2017) 7.1.1 France ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France ADHD Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France ADHD Drugs Sales (K Units) and Market Share by Type 7.3 France ADHD Drugs Sales (K Units) and Market Share by Application 8 Russia ADHD Drugs (Sales, Revenue and Price) 8.1 Russia ADHD Drugs Sales and Value (2012-2017) 8.1.1 Russia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia ADHD Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia ADHD Drugs Sales (K Units) and Market Share by Type 8.3 Russia ADHD Drugs Sales (K Units) and Market Share by Application 9 Benelux ADHD Drugs (Sales, Revenue and Price) 9.1 Benelux ADHD Drugs Sales and Value (2012-2017) 9.1.1 Benelux ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux ADHD Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux ADHD Drugs Sales (K Units) and Market Share by Type 9.3 Benelux ADHD Drugs Sales (K Units) and Market Share by Application 10 Italy ADHD Drugs (Sales, Revenue and Price) 10.1 Italy ADHD Drugs Sales and Value (2012-2017) 10.1.1 Italy ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy ADHD Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy ADHD Drugs Sales (K Units) and Market Share by Type 10.3 Italy ADHD Drugs Sales (K Units) and Market Share by Application 11 Spain ADHD Drugs (Sales, Revenue and Price) 11.1 Spain ADHD Drugs Sales and Value (2012-2017) 11.1.1 Spain ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain ADHD Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain ADHD Drugs Sales (K Units) and Market Share by Type 11.3 Spain ADHD Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe ADHD Drugs Market Forecast (2018-2023) 13.1 Europe ADHD Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe ADHD Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe ADHD Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe ADHD Drugs Price and Trend Forecast (2018-2023) 13.2 Europe ADHD Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe ADHD Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe ADHD Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe ADHD Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe ADHD Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe ADHD Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe ADHD Drugs Price Forecast by Type (2018-2023) 13.4 Europe ADHD Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market ADHD Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe ADHD Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe ADHD Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of ADHD Drugs Table Europe ADHD Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe ADHD Drugs Sales (K Units) Market Share by Types in 2017 Figure Stimulants (Amphetamines, Methylphenidate) Picture Figure Non-Stimulants Picture Figure Antidepressants Picture Table Europe ADHD Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of ADHD Drugs by Applications in 2017 Figure Adults Picture Figure Children Picture Table Europe Market ADHD Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe ADHD Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of ADHD Drugs Table Industry News List of ADHD Drugs Figure Industry Chain Structure of ADHD Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of ADHD Drugs in 2017 Figure Manufacturing Process Analysis of ADHD Drugs Table Raw Materials Sources of ADHD Drugs Major Manufacturers Europe Table Major Buyers of ADHD Drugs Table Eli Lilly Basic Information List Table Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly ADHD Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Eli Lilly ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly ADHD Drugs Volume in Adults and Its Application Share Table Eli Lilly ADHD Drugs Volume in Children and Its Application Share Table Eli Lilly ADHD Drugs Volume in and Its Application Share Table Janssen Pharmaceuticals, Inc. Basic Information List Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Growth Rate (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Adults and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Children and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in and Its Application Share Table Shire Basic Information List Table Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire ADHD Drugs Sales Growth Rate (2012-2017) Figure Shire ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Shire ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Shire ADHD Drugs Volume in Adults and Its Application Share Table Shire ADHD Drugs Volume in Children and Its Application Share Table Shire ADHD Drugs Volume in and Its Application Share Table Perdue Pharma Basic Information List Table Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Growth Rate (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Perdue Pharma ADHD Drugs Volume in Adults and Its Application Share Table Perdue Pharma ADHD Drugs Volume in Children and Its Application Share Table Perdue Pharma ADHD Drugs Volume in and Its Application Share Table Glaxosmith Kline Basic Information List Table Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Growth Rate (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glaxosmith Kline ADHD Drugs Volume in Adults and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in Children and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in and Its Application Share Table Novartis Basic Information List Table Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis ADHD Drugs Sales Growth Rate (2012-2017) Figure Novartis ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Novartis ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis ADHD Drugs Volume in Adults and Its Application Share Table Novartis ADHD Drugs Volume in Children and Its Application Share Table Novartis ADHD Drugs Volume in and Its Application Share Table Celltech Group Basic Information List Table Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Celltech Group ADHD Drugs Sales Growth Rate (2012-2017) Figure Celltech Group ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Celltech Group ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Celltech Group ADHD Drugs Volume in Adults and Its Application Share Table Celltech Group ADHD Drugs Volume in Children and Its Application Share Table Celltech Group ADHD Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson ADHD Drugs Volume in Adults and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in Children and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in and Its Application Share Table Basic Information List Table ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ADHD Drugs Sales Growth Rate (2012-2017) Figure ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Company Basic Information List Table Company ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company ADHD Drugs Sales Growth Rate (2012-2017) Figure Company ADHD Drugs Sales Europe Market Share (%) (2012-2017) Figure Company ADHD Drugs Revenue Europe Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company ADHD Drugs Volume in Adults and Its Application Share Table Company ADHD Drugs Volume in Children and Its Application Share Table Company ADHD Drugs Volume in and Its Application Share Table Europe ADHD Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe ADHD Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe ADHD Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe ADHD Drugs Sales Share by Players/Manufacturers Table Europe ADHD Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe ADHD Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe ADHD Drugs Revenue Market Share (%) Players Figure 2017 Europe ADHD Drugs Revenue Market Share (%) Players Table Europe ADHD Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe ADHD Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of ADHD Drugs by Type (2012-2017) Figure Europe ADHD Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe ADHD Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe ADHD Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of ADHD Drugs by Type (2012-2017) Figure Europe ADHD Drugs Revenue Growth Rate by Type (2012-2017) Table Europe ADHD Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe ADHD Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of ADHD Drugs by Regions (2012-2017) Figure Europe ADHD Drugs Sales Market Share by Regions in 2017 Table Europe ADHD Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe ADHD Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of ADHD Drugs by Regions (2012-2017) Figure Europe ADHD Drugs Revenue Market Share by Regions in 2017 Table Europe ADHD Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe ADHD Drugs Sales Share (%) by Application (2012-2017) Figure Europe ADHD Drugs Sales Market Share by Application (2012-2017) Figure Europe ADHD Drugs Sales Market Share by Application (2012-2017) Figure Germany ADHD Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany ADHD Drugs Sales (K Units) by Type (2012-2017) Table Germany ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Germany ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Germany ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK ADHD Drugs Sales (K Units) by Type (2012-2017) Table UK ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table UK ADHD Drugs Sales (K Units) by Applications (2012-2017) Table UK ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure France ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France ADHD Drugs Sales (K Units) by Type (2012-2017) Table France ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table France ADHD Drugs Sales (K Units) by Applications (2012-2017) Table France ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia ADHD Drugs Sales (K Units) by Type (2012-2017) Table Russia ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Russia ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Russia ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy ADHD Drugs Sales (K Units) by Type (2012-2017) Table Italy ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Italy ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Italy ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux ADHD Drugs Sales (K Units) by Type (2012-2017) Table Benelux ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Benelux ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain ADHD Drugs Sales (K Units) by Type (2012-2017) Table Spain ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Spain ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Spain ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe ADHD Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe ADHD Drugs Price and Trend Forecast (2018-2023) Table Europe ADHD Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe ADHD Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe ADHD Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe ADHD Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe ADHD Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe ADHD Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe ADHD Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe ADHD Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe ADHD Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe ADHD Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe ADHD Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe ADHD Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe ADHD Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Eli Lilly Janssen Pharmaceuticals, Inc. Shire Perdue Pharma Glaxosmith Kline Novartis Celltech Group Johnson & Johnson